Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism

Masahiro Kitada, Shunsuke Yasuda, Takahashi Nana, Kei Ishibashi, Satoshi Hayashi, Satoru Okazaki, Masahiro Kitada, Shunsuke Yasuda, Takahashi Nana, Kei Ishibashi, Satoshi Hayashi, Satoru Okazaki

Abstract

Background: Primary hyperparathyroidism is a rare disease characterized by excessive secretion of parathyroid hormone from parathyroid adenoma, hyperplasia, or malignancy. The clinical symptoms of the condition are those of hypercalcemia. Although the lesions are commonly located in the neck region, in about 1-2 % of cases, the lesions are ectopically located within the mediastinum, where surgical excision using the cervical approach is difficult. The principal treatment of the condition is surgical excision of the lesion. However, some patients require additional surgery because of recurrence due to intraoperative dissemination. Therefore, safe and accurate excision is essential for the treatment. We reviewed the surgical treatment used at our institution for mediastinal parathyroid adenoma that caused primary hyperparathyroidism.

Method: The subjects were four patients with primary hyperparathyroidism due to mediastinal parathyroid adenoma who underwent surgery at our institution within a period of 10 years, between January 2005 and December 2014. All of the patients were female, with a mean age of 64.5 years (range, 55-74 years). The examined variables included background factors, clinical condition, surgical method, and clinical outcome.

Result: In all of the patients, primary hyperparathyroidism was detected with symptoms of hypercalcemia. Laboratory tests revealed a mean serum calcium level of 11.85 mg/dL (range, 11.2-13.2 mg/dL) and a mean parathyroid hormone (intact PTH) level of 304.8 pg/mL (range, 126-586 pg/mL), indicating elevated levels for all patients. Chest computed tomography (CT) revealed tumors with a mean diameter of 2.8 cm (range, 10-45 mm) in the anterior mediastinum in all of the patients. On 99mTC-methoxy isobutyl isonitrile (MIBI) scintigraphy, abnormal accumulation was observed in all of the patients. Regarding the surgical methods, median sternotomy was used for three cases and upper partial sternotomy was used for one case. The surgery was safely and accurately performed, without postoperative complications. After surgery, the serum calcium levels immediately returned to normal and the symptoms improved.

Conclusion: We performed excision safely and accurately in all of the patients. In tumor identification, 99mTC-MIBI scintigraphy was useful. Accurate tumor identification and selection of the optimal surgical method are important for prevention of recurrence due to intraoperative dissemination.

Figures

Fig. 1
Fig. 1
Computerized tomography. Mediastinum parathyroid adenoma or hyperplasia legion (arrow)
Fig. 2
Fig. 2
99mTc MIBI scan. Mediastinum parathyroid adenoma or hyperplasia lesion (arrow). Image of case3 and 4 are subtraction image

References

    1. Ogawa T, Tsuji E, Kanauchi H, Yamada K, Mimura Y, Kaminishi M. Excision of postesophageal parathyroid adenoma in posterior mediastinum with intraoperative 99mTechnetium sestamibi scanning. Ann Thorac Surg. 2007;84(5):1754–6. doi: 10.1016/j.athoracsur.2007.05.055.
    1. Medrano C, Hazelrigg SR, Landreneau RJ, Boley TM, Shawgo T, Grasch A. Thoracoscopic resection of ectopic parathyroid glands. Ann Thorac Surg. 2000;69(1):221–3. doi: 10.1016/S0003-4975(99)01127-3.
    1. Abbas F, Biyabani SR, Memon A, Talati J. Mediastinal parathyroid adenoma causing primary hyperparathyroidism. J Pak Med Assoc. 2007;57(2):93–5.
    1. Lo CY, Kung AW, Lam KS. Surgical treatment for primary hyperparathyroidism. Chin Med J (Engl) 1997;110(8):612–6.
    1. Lassen T, Friis-Hansen L, Rasmussen AK, Knigge U, Feldt-Rasmussen U. Primary hyperparathyroidism in young people. When should we perform genetic testing for multiple endocrine neoplasia 1 (MEN-1)? J Clin Endocrinol Metab. 2014;99(11):3983–7. doi: 10.1210/jc.2013-4491.
    1. Ng P, Lenzo NP, McCarthy MC, Thompson I, Leedman PJ. Ectopic parathyroid adenoma localised with sestamibi SPECT and image-fused computed tomography. Med J Aust. 2003;179(9):485–7.
    1. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, Even-Sapir E, Chisin R, Israel O. Technetium-99 m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2006;30(1):76–83. doi: 10.1007/s00268-005-7849-2.
    1. Gough I. Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ J Surg. 2006;76(12):1048–50. doi: 10.1111/j.1445-2197.2006.03931.x.
    1. Moriyama T, Kageyama K, Nigawara T, Koyanagi M, Fukuda I, Yashiro H, Suda T. Diagnosis of a case of ectopic parathyroid adenoma on the early image of 99mTc-MIBI scintigram. Endocr J. 2007;54(3):437–40. doi: 10.1507/endocrj.K06-164.
    1. Sagan D, Goździuk K. Surgical treatment of mediastinal parathyroid adenoma: rationale for intraoperative parathyroid hormone monitoring. Ann Thorac Surg. 2010;89(6):1750–5. doi: 10.1016/j.athoracsur.2010.02.076.
    1. Singh Ospina N, Thompson GB, Lee RA, Reading CC, Young WF., Jr Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2015;100(1):87–90. doi: 10.1210/jc.2014-3255.
    1. Dinçer SI, Demir A, Kara HV, Günlüoglu MZ. Thoracoscopic removal of a maternal mediastinal ectopic parathyroid adenoma causing neonatal hypocalcemia: a case report. Ann Thorac Cardiovasc Surg. 2008;14(5):325–8.
    1. Chae AW, Perricone A, Brumund KT, Bouvet M. Outpatient video-assisted thoracoscopic surgery (VATS) for ectopic mediastinal parathyroid adenoma: a case report and review of the literature. J Laparoendosc Adv Surg Tech A. 2008;18(3):383–90. doi: 10.1089/lap.2007.0124.
    1. Liman ST, Topcu S, Dervisoglu E, Gorur GD, Elicora A, Burc K, Akgul AG. Excision of ectopic mediastinal parathyroid adenoma via parasternal videomediastinoscopy. Ann Thorac Cardiovasc Surg. 2014;20(1):67–9. doi: 10.5761/atcs.cr.12.01960.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren